Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imaging Canada Liquidating Corp IMRSQ

IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.


GREY:IMRSQ - Post by User

Post by BIBBLEYon Jun 28, 2013 6:36pm
226 Views
Post# 21580582

Interesting Data ...

Interesting Data ...

Is this new on Imris web site?

INTRAOPERATIVE MR: MAKING AN IMPACT

https://www.imris.com/product/clinical-evidence

Over the last two decades, clinicians, scientists and engineers have been developing intraoperative imaging systems to improve surgical treatment. Today, leading neurosurgical hospitals indicate that in over 40% of all cases, the surgeon chose to modify their approach based on new information from intraoperative MR imaging that would otherwise not have been available until after completing the procedure.

Furthermore, in over 55% of glioma cases, additional brain tumor was identified and resected after iMRI. These centers report significant improvements – about 30 percentage points – in the portion of cases achieving gross/total tumor resection with intraoperative MR compared to cases without it. Considering that “improved outcome among adult patients with hemispheric LGG [glioma] is predicted by greater EOR [extent of resection]”9, iMRI is making a significant difference in neurosurgery.

They just tweeted it #braintumor #neurosurgery #imri #glioma

Important individuals, professionals and institutions follow this stuff.


<< Previous
Bullboard Posts
Next >>